Login to Your Account



Many Faces of Monetization

Celera's Hidden Treasure: A 'Royal' Road to Payoff?

By Trista Morrison


Monday, February 15, 2010
Last week, the Biotechnology Value Fund (BVF) proposed that Celera Corp. separate its low margin diagnostics business from its potentially high-margin drug royalty stream.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription